Conversely, patients with COPB2 alterations in kidney cancer exhibited worse prognosis in terms of OS (P = 2.49e − 7), DFS (P = 1.74e − 8), PFS (P = 1.558e − 5), and DSS (P = 8.62e − 8). This evidence concerns the gene COPB2 and kidney cancer.